Anzalone Christopher Richard
CIK 0001423029 Name as filed on the most recent filing
Filed as Anzalone Christopher Richard (42)
111 transaction lines · from 42 filings · filed 2008-08-25 to 2026-01-05 The span is the filing dates this catalog holds, not the entity's full filing history. Absence here is not evidence of absence at the SEC.
A line appears here when the filing that carries it names this CIK as a reporting owner, not only when the parser picked this CIK as the line's primary owner. That is why a joint filing appears on both owners' pages rather than vanishing from the second one. The catalog never merges two CIKs into one person and never splits one CIK into two: identity here is the SEC's own identifier and nothing else.
Issuers this insider has filed against
Ordered by last-seen filing date, newest first. Roles are as filed on the Form 4 and are not normalised.
This container could not be filled from the store. It is showing nothing because a read failed, not because no insider filed: those are different facts and this catalog will not let one stand in for the other. The last ingest the store recorded was 2026-08-20 05:22 UTC.
No issuer is recorded
The catalog holds no filing linking this CIK to an issuer.
Transactions
Every stored Form 4 line naming this reporting owner, newest transaction date first. Each row links to the filing it came from.
111 transactions · Newest transaction date first, id breaking the tie.
This container could not be filled from the store. It is showing nothing because a read failed, not because no insider filed: those are different facts and this catalog will not let one stand in for the other. The last ingest the store recorded was 2026-08-20 05:22 UTC.
| Direction | Date | Issuer | Code | Shares | Price | Value USD | Filing |
|---|---|---|---|---|---|---|---|
| 2026-01-02 |
Arrowhead Pharmaceuticals, Inc. ARWR |
S, Open-market sale | 7,416 disposed | 65.88 | 488,566.08 | Form 4, filing 0001423029-26-000001 | |
| 2026-01-02 |
Arrowhead Pharmaceuticals, Inc. ARWR |
S, Open-market sale | 5,771 disposed | 66.39 | 383,136.69 | Form 4, filing 0001423029-26-000001 | |
| 2025-12-29 |
Arrowhead Pharmaceuticals, Inc. ARWR |
S, Open-market sale | 35,181 disposed | 69.33 | 2,439,098.73 | Form 4, filing 0001423029-25-000009 | |
| 2025-12-29 |
Arrowhead Pharmaceuticals, Inc. ARWR |
S, Open-market sale | 16,545 disposed | 68.69 | 1,136,476.05 | Form 4, filing 0001423029-25-000009 | |
| 2025-12-22 |
Arrowhead Pharmaceuticals, Inc. ARWR |
S, Open-market sale | 10,012 disposed | 68.33 | 684,119.96 | Form 4, filing 0001423029-25-000007 | |
| 2025-12-22 |
Arrowhead Pharmaceuticals, Inc. ARWR |
S, Open-market sale | 2,574 disposed | 68.85 | 177,219.90 | Form 4, filing 0001423029-25-000007 | |
| 2025-12-19 |
Arrowhead Pharmaceuticals, Inc. ARWR |
S, Open-market sale | 8,147 disposed | 68.01 | 554,077.47 | Form 4, filing 0001423029-25-000007 | |
| 2025-12-19 |
Arrowhead Pharmaceuticals, Inc. ARWR |
S, Open-market sale | 3,979 disposed | 66.67 | 265,279.93 | Form 4, filing 0001423029-25-000007 | |
| 2025-12-19 |
Arrowhead Pharmaceuticals, Inc. ARWR |
S, Open-market sale | 1,319 disposed | 68.48 | 90,325.12 | Form 4, filing 0001423029-25-000007 | |
| 2025-12-17 |
Arrowhead Pharmaceuticals, Inc. ARWR |
S, Open-market sale | 46,287 disposed | 63.55 | 2,941,538.85 | Form 4, filing 0001423029-25-000005 | |
| 2025-12-17 |
Arrowhead Pharmaceuticals, Inc. ARWR |
S, Open-market sale | 35,750 disposed | 64.51 | 2,306,232.50 | Form 4, filing 0001423029-25-000005 | |
| 2025-12-17 |
Arrowhead Pharmaceuticals, Inc. ARWR |
S, Open-market sale | 1,981 disposed | 66.30 | 131,340.30 | Form 4, filing 0001423029-25-000005 | |
| 2025-12-17 |
Arrowhead Pharmaceuticals, Inc. ARWR |
S, Open-market sale | 982 disposed | 65.53 | 64,350.46 | Form 4, filing 0001423029-25-000005 | |
| 2025-12-16 |
Arrowhead Pharmaceuticals, Inc. ARWR |
S, Open-market sale | 14,095 disposed | 62.12 | 875,581.40 | Form 4, filing 0001423029-25-000003 | |
| 2025-12-16 |
Arrowhead Pharmaceuticals, Inc. ARWR |
S, Open-market sale | 10,963 disposed | 61.25 | 671,483.75 | Form 4, filing 0001423029-25-000003 | |
| 2025-12-16 |
Arrowhead Pharmaceuticals, Inc. ARWR |
S, Open-market sale | 8,476 disposed | 62.94 | 533,479.44 | Form 4, filing 0001423029-25-000003 | |
| 2025-12-16 |
Arrowhead Pharmaceuticals, Inc. ARWR |
S, Open-market sale | 8,416 disposed | 60.51 | 509,252.16 | Form 4, filing 0001423029-25-000003 | |
| 2025-12-16 |
Arrowhead Pharmaceuticals, Inc. ARWR |
S, Open-market sale | 6,661 disposed | 64.29 | 428,235.69 | Form 4, filing 0001423029-25-000003 | |
| 2025-12-16 |
Arrowhead Pharmaceuticals, Inc. ARWR |
S, Open-market sale | 3,221 disposed | 67.87 | 218,609.27 | Form 4, filing 0001423029-25-000003 | |
| 2025-12-16 |
Arrowhead Pharmaceuticals, Inc. ARWR |
S, Open-market sale | 1,300 disposed | 65.77 | 85,501.00 | Form 4, filing 0001423029-25-000003 | |
| 2025-12-16 |
Arrowhead Pharmaceuticals, Inc. ARWR |
S, Open-market sale | 1,000 disposed | 64.96 | 64,960.00 | Form 4, filing 0001423029-25-000003 | |
| 2025-12-16 |
Arrowhead Pharmaceuticals, Inc. ARWR |
S, Open-market sale | 166 disposed | 66.77 | 11,083.82 | Form 4, filing 0001423029-25-000003 | |
| 2025-12-15 |
Arrowhead Pharmaceuticals, Inc. ARWR |
S, Open-market sale | 100,532 disposed | 68.67 | 6,903,532.44 | Form 4, filing 0001423029-25-000003 | |
| 2025-12-15 |
Arrowhead Pharmaceuticals, Inc. ARWR |
S, Open-market sale | 21,321 disposed | 69.28 | 1,477,118.88 | Form 4, filing 0001423029-25-000003 | |
| 2025-12-15 |
Arrowhead Pharmaceuticals, Inc. ARWR |
S, Open-market sale | 8,147 disposed | 69.96 | 569,964.12 | Form 4, filing 0001423029-25-000003 | |
| 2025-04-11 |
Arrowhead Pharmaceuticals, Inc. ARWR |
S, Open-market sale | 50,800 disposed | 11.49 | 583,692.00 | Form 4, filing 0001628280-25-017592 | |
| 2025-04-10 |
Arrowhead Pharmaceuticals, Inc. ARWR |
S, Open-market sale | 50,000 disposed | 10.87 | 543,500.00 | Form 4, filing 0001628280-25-017592 | |
| 2025-04-09 |
Arrowhead Pharmaceuticals, Inc. ARWR |
S, Open-market sale | 35,305 disposed | 9.93 | 350,578.65 | Form 4, filing 0001628280-25-017592 | |
| 2025-04-09 |
Arrowhead Pharmaceuticals, Inc. ARWR |
S, Open-market sale | 3,400 disposed | 10.75 | 36,550.00 | Form 4, filing 0001628280-25-017592 | |
| 2025-04-09 |
Arrowhead Pharmaceuticals, Inc. ARWR |
S, Open-market sale | 1,617 disposed | 11.76 | 19,015.92 | Form 4, filing 0001628280-25-017592 | |
| 2025-03-13 |
Arrowhead Pharmaceuticals, Inc. ARWR |
S, Open-market sale | 51,425 disposed | 15.07 | 774,974.75 | Form 4, filing 0001628280-25-013210 | |
| 2025-03-04 |
Arrowhead Pharmaceuticals, Inc. ARWR |
S, Open-market sale | 133,333 disposed | 17.02 | 2,269,327.66 | Form 4, filing 0001628280-25-010672 | |
| 2025-03-03 |
Arrowhead Pharmaceuticals, Inc. ARWR |
S, Open-market sale | 166,667 disposed | 18.03 | 3,005,006.01 | Form 4, filing 0001628280-25-010672 | |
| 2025-01-02 |
Arrowhead Pharmaceuticals, Inc. ARWR |
S, Open-market sale | 11,520 disposed | 19.05 | 219,456.00 | Form 4, filing 0001628280-25-000673 | |
| 2024-12-23 |
Arrowhead Pharmaceuticals, Inc. ARWR |
S, Open-market sale | 12,563 disposed | 19.59 | 246,109.17 | Form 4, filing 0001628280-24-052347 | |
| 2024-12-18 |
Arrowhead Pharmaceuticals, Inc. ARWR |
S, Open-market sale | 12,653 disposed | 20.52 | 259,639.56 | Form 4, filing 0001628280-24-052267 | |
| 2024-12-18 |
Arrowhead Pharmaceuticals, Inc. ARWR |
S, Open-market sale | 8,260 disposed | 21.74 | 179,572.40 | Form 4, filing 0001628280-24-052267 | |
| 2024-12-18 |
Arrowhead Pharmaceuticals, Inc. ARWR |
S, Open-market sale | 5,799 disposed | 22.12 | 128,273.88 | Form 4, filing 0001628280-24-052267 | |
| 2024-01-31 |
Arrowhead Pharmaceuticals, Inc. ARWR |
S, Open-market sale | 37,769 disposed | 32.16 | 1,214,651.04 | Form 4, filing 0001628280-24-003097 | |
| 2024-01-31 |
Arrowhead Pharmaceuticals, Inc. ARWR |
S, Open-market sale | 19,730 disposed | 32.71 | 645,368.30 | Form 4, filing 0001628280-24-003097 | |
| 2024-01-02 |
Arrowhead Pharmaceuticals, Inc. ARWR |
S, Open-market sale | 5,318 disposed | 31.25 | 166,187.50 | Form 4, filing 0001628280-24-000478 | |
| 2024-01-02 |
Arrowhead Pharmaceuticals, Inc. ARWR |
S, Open-market sale | 4,634 disposed | 30.74 | 142,449.16 | Form 4, filing 0001628280-24-000478 | |
| 2023-12-20 |
Arrowhead Pharmaceuticals, Inc. ARWR |
S, Open-market sale | 12,000 disposed | 28.54 | 342,480.00 | Form 4, filing 0001628280-23-042646 | |
| 2023-10-25 |
Arrowhead Pharmaceuticals, Inc. ARWR |
S, Open-market sale | 24,338 disposed | 24.21 | 589,222.98 | Form 4, filing 0001628280-23-035430 | |
| 2023-09-18 |
Arrowhead Pharmaceuticals, Inc. ARWR |
S, Open-market sale | 31,523 disposed | 28.00 | 882,644.00 | Form 4, filing 0001628280-23-032707 | |
| 2023-09-18 |
Arrowhead Pharmaceuticals, Inc. ARWR |
S, Open-market sale | 26,232 disposed | 28.27 | 741,578.64 | Form 4, filing 0001628280-23-032707 | |
| 2023-05-04 |
Arrowhead Pharmaceuticals, Inc. ARWR |
S, Open-market sale | 25,992 disposed | 40.02 | 1,040,199.84 | Form 4, filing 0001628280-23-016223 | |
| 2023-05-04 |
Arrowhead Pharmaceuticals, Inc. ARWR |
S, Open-market sale | 24,008 disposed | 38.97 | 935,591.76 | Form 4, filing 0001628280-23-016223 | |
| 2023-05-03 |
Arrowhead Pharmaceuticals, Inc. ARWR |
S, Open-market sale | 54,928 disposed | 39.14 | 2,149,881.92 | Form 4, filing 0001628280-23-016223 | |
| 2022-02-11 |
Arrowhead Pharmaceuticals, Inc. ARWR |
S, Open-market sale | 61,482 disposed | 50.90 | 3,129,433.80 | Form 4, filing 0001209191-22-009052 |
This column is intentionally blank
No transaction line is stored for this reporting owner, though the catalog holds filings naming them. That happens when the filings report only holdings or only positions the store does not carry, and when a parse failed; each filing page states its own parse status.
- S, Open-market sale
- Open-market sale
Every value is as reported on the Form 4. A price the filing did not report is marked Not reported and no value is computed from it. Codes outside the open market, drawn in grey behind a dashed rule, are compensation and administrative machinery rather than a decision to trade at the prevailing price.
What this insider's stored lines contain
Exact counts over every stored line for this entity. This is a statement of composition, not a filter: the only filter this page offers is the open-market one above, because that is the only one an index serves today.
- Open-market purchase 5
- Open-market sale 106
- Option exercise 0
- Grant or award 0
- Tax withholding 0
- Disposition to the issuer 0
- In-the-money option exercise 0
How to cite this page
ebomi catalog. Anzalone Christopher Richard, insider transactions. Retrieved 2026-08-21 from https://ebomi.com/insider/0001423029
Balogh, A. Insider trading. Scientific Data 10, 237 (2023) doi:10.1038/s41597-023-02147-6